These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3803416)

  • 61. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy.
    Sachdeo RC; Sachdeo SK; Walker SA; Kramer LD; Nayak RK; Doose DR
    Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of felbamate on plasma levels of carbamazepine and its metabolites.
    Albani F; Theodore WH; Washington P; Devinsky O; Bromfield E; Porter RJ; Nice FJ
    Epilepsia; 1991; 32(1):130-2. PubMed ID: 1985822
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Carbamazepine plus stiripentol: is polytherapy by design possible?
    Lockard JS; Levy RH
    Epilepsia; 1988; 29(4):476-81. PubMed ID: 3391151
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Controlled release carbamazepine: cognitive side effects in patients with epilepsy.
    Aldenkamp AP; Alpherts WC; Moerland MC; Ottevanger N; Van Parys JA
    Epilepsia; 1987; 28(5):507-14. PubMed ID: 3653052
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fluctuations of carbamazepine concentrations during the day for two slow-release preparations.
    May T; Rambeck B
    Ther Drug Monit; 1989; 11(1):21-4. PubMed ID: 2911848
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term observation of the relation between pain intensity and serum carbamazepine concentration in elderly patients with trigeminal neuralgia.
    Umino M; Ohwatari T; Shimoyama K; Nagao M
    J Oral Maxillofac Surg; 1993 Dec; 51(12):1338-44; discussion 1344-5. PubMed ID: 8229414
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Signs and symptoms of carbamazepine overdose.
    Schmidt S; Schmitz-Buhl M
    J Neurol; 1995 Feb; 242(3):169-73. PubMed ID: 7751861
    [TBL] [Abstract][Full Text] [Related]  

  • 70. On-Site Biolayer Interferometry-Based Biosensing of Carbamazepine in Whole Blood of Epileptic Patients.
    Bian S; Tao Y; Zhu Z; Zhu P; Wang Q; Wu H; Sawan M
    Biosensors (Basel); 2021 Dec; 11(12):. PubMed ID: 34940273
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunomodulating properties of carbamazepine in mice.
    Pacifici R; Di Carlo S; Bacosi A; Pichini S; Zuccaro P
    Int J Immunopharmacol; 1992 May; 14(4):605-11. PubMed ID: 1521928
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preliminarily Analysis of Carbamazepine (CBZ) C0 in Patients Visited Isfahan Epileptic Clinics.
    Tolou-Ghamari Z; Najafi MR; Habibabadi JM; Zare M
    Int J Prev Med; 2013 May; 4(Suppl 2):S343-6. PubMed ID: 23776749
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transformation Products of Carbamazepine (CBZ) After Ozonation and their Toxicity Evaluation Using
    Dwivedi K; Rudrashetti AP; Chakrabarti T; Pandey RA
    Indian J Microbiol; 2018 Jun; 58(2):193-200. PubMed ID: 29651178
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects.
    Riva R; Albani F; Ambrosetto G; Contin M; Cortelli P; Perucca E; Baruzzi A
    Epilepsia; 1984 Aug; 25(4):476-81. PubMed ID: 6540170
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of a single dose of dextromethorphan on psychomotor performance and working memory capacity.
    Al-Kuraishy HM; Al-Gareeb AI; Ashor AW
    Indian J Psychol Med; 2012 Apr; 34(2):140-3. PubMed ID: 23162189
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impairment of psychomotor function at modest plasma concentrations of carbamazepine after administration of the liquid suspension to naive subjects.
    Wildin JD; Pleuvry BJ; Mawer GE
    Br J Clin Pharmacol; 1993 Jan; 35(1):14-9. PubMed ID: 8448063
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Psychomotor impairment and anticonvulsant therapy in adult epileptic patients.
    Brodie MJ; McPhail E; Macphee GJ; Larkin JG; Gray JM
    Eur J Clin Pharmacol; 1987; 31(6):655-60. PubMed ID: 3830252
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients.
    Gillham RA; Williams N; Wiedmann K; Butler E; Larkin JG; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):929-33. PubMed ID: 3204401
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man.
    Macphee GJ; Mitchell JR; Wiseman L; McLellan AR; Park BK; McInnes GT; Brodie MJ
    Br J Clin Pharmacol; 1988 Jan; 25(1):59-66. PubMed ID: 3130892
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A double-blind comparison of conventional and controlled-release carbamazepine in healthy subjects.
    Larkin JG; McLellan A; Munday A; Sutherland M; Butler E; Brodie MJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):313-22. PubMed ID: 2655682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.